Document is current
Any future updates will be listed below
-
Authors
Wilk, Mateusz https://orcid.org/0000-0001-7967-0880
Michelsen, Brigitte https://orcid.org/0000-0003-0103-2840
Łosińska, Katarzyna https://orcid.org/0000-0003-2801-6584
Kavanaugh, Arthur https://orcid.org/0000-0001-6942-5830
Korkosz, Mariusz https://orcid.org/0000-0002-1749-9739
Haugeberg, Glenn https://orcid.org/0000-0002-9279-5191
-
Funding
Funding for this research was provided by:
Pfizer (Unrestricted Research Grant number 5714134)
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 4 January 2024
First Online: 6 February 2024
Declarations
:
: GH is the founder and previous shareholder in the company manufacturing the GoTreatIt Rheuma tool. BM has received consultant fees from Novartis and research grant from Novartis (paid to the employer). MW, KŁ, AK, and MK have declared no conflicts of interest.
: Written informed consent was obtained from all individual participants included in the study. Data in the study were anonymized.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
